The Amgen-MIT Biomanufacturing Educational Initiative supports the development of a new MIT online course. The new course, Making Biologic Medicines for Patients: The Principles of Biopharmaceutical Manufacturing, highlights the complexity and importance of biologics manufacturing, increases global undergraduate exposure to the field, and encourages students to pursue careers in manufacturing life-saving medications. More than 1,100 students from nearly 140 countries have completed the course so far. Enrollment is open to anyone on the global edX platform.
Learn more about this program by visiting